Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
1.300
+0.412 (46.40%)
At close: Dec 20, 2024, 4:00 PM
1.280
-0.020 (-1.54%)
After-hours: Dec 20, 2024, 7:59 PM EST
Prelude Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 11.13 | 25.29 | 30.61 | 31.83 | 218.31 | 18.88 | Upgrade
|
| Short-Term Investments | 142.49 | 207.64 | 171.12 | 259.41 | - | - | Upgrade
|
| Cash & Short-Term Investments | 153.63 | 232.94 | 201.73 | 291.23 | 218.31 | 18.88 | Upgrade
|
| Cash Growth | -33.35% | 15.47% | -30.73% | 33.40% | 1056.36% | 21.06% | Upgrade
|
| Prepaid Expenses | 2.76 | 2.65 | 2.65 | 3.88 | 2.5 | 1.35 | Upgrade
|
| Total Current Assets | 156.39 | 235.59 | 204.38 | 295.12 | 220.81 | 20.22 | Upgrade
|
| Property, Plant & Equipment | 36.38 | 37.74 | 6.7 | 5.64 | 2.48 | 1.65 | Upgrade
|
| Other Long-Term Assets | 4.45 | 4.34 | 9.42 | 4.35 | 0.3 | - | Upgrade
|
| Total Assets | 197.22 | 277.67 | 220.5 | 305.1 | 223.59 | 21.87 | Upgrade
|
| Accounts Payable | 5.92 | 4.58 | 6.78 | 7.84 | 3.92 | 1.97 | Upgrade
|
| Accrued Expenses | 12.78 | 14.82 | 12.57 | 9.53 | 7.04 | 2.6 | Upgrade
|
| Current Portion of Leases | 2.72 | 1.48 | 1.83 | 1.74 | - | 0.26 | Upgrade
|
| Other Current Liabilities | 0.8 | 0.95 | 0.52 | 0.09 | 0.42 | - | Upgrade
|
| Total Current Liabilities | 22.22 | 21.83 | 21.7 | 19.2 | 11.38 | 4.84 | Upgrade
|
| Long-Term Leases | 15.41 | 15.41 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 3.15 | 3.34 | 3.36 | - | 0.03 | 0.01 | Upgrade
|
| Total Liabilities | 40.79 | 40.58 | 25.06 | 19.2 | 11.41 | 4.84 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0 | - | Upgrade
|
| Additional Paid-In Capital | 711.09 | 693.25 | 531.68 | 505.72 | 319.61 | 1.09 | Upgrade
|
| Retained Earnings | -554.83 | -456.39 | -334.56 | -219.12 | -107.43 | -50.5 | Upgrade
|
| Comprehensive Income & Other | 0.17 | 0.22 | -1.69 | -0.71 | - | - | Upgrade
|
| Total Common Equity | 156.43 | 237.09 | 195.44 | 285.9 | 212.18 | -49.41 | Upgrade
|
| Shareholders' Equity | 156.43 | 237.09 | 195.44 | 285.9 | 212.18 | 17.03 | Upgrade
|
| Total Liabilities & Equity | 197.22 | 277.67 | 220.5 | 305.1 | 223.59 | 21.87 | Upgrade
|
| Total Debt | 18.14 | 16.89 | 1.83 | 1.74 | - | 0.26 | Upgrade
|
| Net Cash (Debt) | 135.49 | 216.05 | 199.9 | 289.49 | 218.31 | 18.62 | Upgrade
|
| Net Cash Growth | -41.10% | 8.08% | -30.95% | 32.61% | 1072.38% | 19.40% | Upgrade
|
| Net Cash Per Share | 1.83 | 3.58 | 4.22 | 6.29 | 17.49 | 11.16 | Upgrade
|
| Filing Date Shares Outstanding | 55.04 | 54.89 | 47.71 | 47.02 | 45.37 | 2.26 | Upgrade
|
| Total Common Shares Outstanding | 55.03 | 54.89 | 47.7 | 46.99 | 42.49 | 1.83 | Upgrade
|
| Working Capital | 134.16 | 213.76 | 182.68 | 275.91 | 209.43 | 15.39 | Upgrade
|
| Book Value Per Share | 2.84 | 4.32 | 4.10 | 6.08 | 4.99 | -27.06 | Upgrade
|
| Tangible Book Value | 156.43 | 237.09 | 195.44 | 285.9 | 212.18 | -49.41 | Upgrade
|
| Tangible Book Value Per Share | 2.84 | 4.32 | 4.10 | 6.08 | 4.99 | -27.06 | Upgrade
|
| Machinery | - | 8.97 | 5.72 | 4.38 | 2.72 | 1.89 | Upgrade
|
| Construction In Progress | - | 0.34 | 1.64 | 0.67 | - | - | Upgrade
|
| Leasehold Improvements | - | 1.58 | 0.88 | 0.88 | 0.45 | 0.31 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.